Finance Watch: VC Enthusiasm For Biopharma Continues As 5AM Ventures Raises $750m
Antimicrobial Firms Get A Boost From Two Sources
Private Company Edition: 5AM revealed two funds totaling $450m and $300m, V-Bio raised a €110m venture capital fund and AXA IM Alts committed $500m for health care private equity deals. Also, TRIANA launched with $110m and the AMR Action Fund backs Adaptive Phage Therapeutics.
